[ad_1] Honored to present at the Macula Society Annual Meeting today! #eyes #retina #macula #maculardegeneration #AMD #ophthalmology #clinicalresearch https://t.co/mrUMR1zRsG [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @ThomasCiullaMD: Looking forward to presenting at Medicine 2042! https://t.co/t233EJFZV0 The next two decades will be filled with new in… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @RetinalPhys: NEW PRODUCT APPLICATIONS: Xipere Suprachoroidal Injection for Uveitis https://t.co/KB1AAkjpXf https://t.co/Iith6KJ0Xl
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Looking forward to presenting at Medicine 2042! https://t.co/t233EJFZV0 The next two decades will be filled with new innovations in sustained release technology, drug delivery, gene & cell therapy, which will benefit those with untreatable genetic and chronic diseases. https://t.co/e2zo8iDszU [ad_2] Source by Thomas Ciulla, …
[ad_1]
Looking forward to presenting “The #Suprachoroidal Space and Suprachoroidal Delivery for Clinicians” at INNOVATE RETINA, hosted by Stanford Medicine/Byers Eye Institute on Sat, June 4!
Please join virtually! Complimentary registration: https://t.co/FI3EQzPVDC
#eye #retina #AMD https://t.co/QIRJiFXzRv
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Just published: https://t.co/iavHrQFgR9 “Longer-Term Anti-VEGF Therapy Outcomes in Neovascular #AMD, #DME, and RVO Macular Edema: Clinical Outcomes in 130,247 Eyes”. More effective and longer acting therapies are needed for these leading causes of legal blindness. #eyes #retina https://t.co/roratuqzkp [ad_2] Source by Thomas Ciulla, MD, …
[ad_1] Honored to present at the @RetinaWCongress panel discussion on “New Pathways in Retinal Diseases”. @RWCRetina #eyes #retina #macula #ophthalmology #biotech #biotechnology #medicine #clinicalresearch #clinicaltrials #drugdevelopment #suprachoroidal #xipere https://t.co/a5X8MEIMHo [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @TheLens_oph: Predicting the future with OCT biomarkers for macular edema in non-infectious #uveitis. Read more on @ThomasCiullaMD’s lat… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.